» Articles » PMID: 31742928

PD-1 Expression Affects Cytokine Production by ILC2 and is Influenced by Peroxisome Proliferator-activated Receptor-γ

Abstract

Introduction: Innate lymphoid cells (ILCs) can provide early cytokine help against a variety of pathogens in the lungs and gastrointestinal tract. Type 2 ILC (ILC2) are comparable to T helper 2 cells found in the adaptive immune system, which secrete cytokines such as interleukin 5 (IL-5) and IL-13 and have been found to play roles in host defense against helminth infections and in allergic responses. Recent studies have identified that programmed cell death protein 1 (PD-1) and peroxisome proliferator activated receptor-γ (PPAR-γ) are highly expressed by ILC2. We examined whether PD-1 plays a role in ILC2 function and whether there was any connection between PD-1 and PPAR-γ METHODS: To ensure that only innate immune cells were present, ILC2 cells were examined from RAG1 and PD-1 xRAG1 mice under steady-state or following inoculation with IL-33. We also tested ILC2 generated from bone marrow of RAG1 and PD-1 xRAG1 mice for their production of cytokines. These in vitro-derived ILC2 were also exposed to agonist and antagonist of PPAR-γ.

Results: We found that ILC2 from PD-1 xRAG1 mice had reduced frequencies of IL-5 and IL-13 producing cells both in vitro upon IL-33 stimulation and in vivo following intraperitoneal administration of IL-33 when compared with ILC2 from RAG1 mice. However, by adding IL-2, IL-25, and thymic stromal lymphopoietin to the in vitro cultures, the frequency of IL-5 and IL-13 expressing ILC2 from PD-1 xRAG1 mice became similar to the frequency observed for ILC2 from RAG1 mice. In addition, PPAR-γ agonists and antagonists were found to increase and decrease PD-1 expression on ILC2 respectively.

Conclusions: These findings illustrate that chronic loss of PD-1 plays a role in ILC2 function and PD-1 expression can be modulated by PPAR-γ.

Citing Articles

Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab.

Reuthner K, Aubele P, Menhart K, Rath P, Harrer D, Herr W Front Pharmacol. 2024; 15:1334233.

PMID: 38444946 PMC: 10912635. DOI: 10.3389/fphar.2024.1334233.


Nr4a1 marks a distinctive ILC2 activation subset in the mouse inflammatory lung.

Xu S, Zhang Y, Liu X, Liu H, Zou X, Zhang L BMC Biol. 2023; 21(1):218.

PMID: 37833706 PMC: 10576290. DOI: 10.1186/s12915-023-01690-3.


Mitogen-Activated Protein Kinase and Nuclear Hormone Receptor Crosstalk in Cancer Immunotherapy.

Burgermeister E Int J Mol Sci. 2023; 24(17).

PMID: 37686465 PMC: 10488039. DOI: 10.3390/ijms241713661.


Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies.

Tsuji A, Yoshikawa S, Morikawa S, Ikeda Y, Taniguchi K, Sawamura H Explor Target Antitumor Ther. 2023; 4(3):460-473.

PMID: 37455830 PMC: 10344894. DOI: 10.37349/etat.2023.00145.


The impact of peroxisome proliferator-activated receptor-γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy.

Chiang C, Chang Y, Wang S, Chen Y, See X, Peng C Cancer Med. 2023; 12(8):9583-9588.

PMID: 36825549 PMC: 10166924. DOI: 10.1002/cam4.5734.


References
1.
Taylor S, Huang Y, Mallett G, Stathopoulou C, Felizardo T, Sun M . PD-1 regulates KLRG1 group 2 innate lymphoid cells. J Exp Med. 2017; 214(6):1663-1678. PMC: 5461001. DOI: 10.1084/jem.20161653. View

2.
Chen T, Tibbitt C, Feng X, Stark J, Rohrbeck L, Rausch L . PPAR-γ promotes type 2 immune responses in allergy and nematode infection. Sci Immunol. 2017; 2(9). DOI: 10.1126/sciimmunol.aal5196. View

3.
Ellyard J, Simson L, Parish C . Th2-mediated anti-tumour immunity: friend or foe?. Tissue Antigens. 2007; 70(1):1-11. DOI: 10.1111/j.1399-0039.2007.00869.x. View

4.
Mombaerts P, Iacomini J, Johnson R, Herrup K, Tonegawa S, Papaioannou V . RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992; 68(5):869-77. DOI: 10.1016/0092-8674(92)90030-g. View

5.
Halim T, Hwang Y, Scanlon S, Zaghouani H, Garbi N, Fallon P . Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol. 2015; 17(1):57-64. PMC: 4685755. DOI: 10.1038/ni.3294. View